Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2022-01-03 Sale |
2022-01-05 4:52 pm |
NovoCure Ltd | NVCR | Burke William Patrick Chief Human Resources Officer |
3,951 | $76 | $300,263 | 56,968 (Direct) |
View |
| 2021-11-26 Purchase |
2021-11-29 4:48 pm |
NovoCure Ltd | NVCR | Danziger Asaf Chief Executive Officer |
4,974 | $102.44 | $509,539 | 13,276 (Direct) |
View |
| 2021-11-02 Sale |
2021-11-03 4:11 pm |
NovoCure Ltd | NVCR | Cordova Ashley Chief Financial Officer |
209 | $107.28 | $22,421 | 41,758 (Direct) |
View |
| 2021-09-02 Sale |
2021-09-07 4:39 pm |
NovoCure Ltd | NVCR | Leonard Frank X Chief Development Officer |
540 | $138.23 | $74,645 | 87,153 (Direct) |
View |
| 2021-09-02 Sale |
2021-09-07 4:37 pm |
NovoCure Ltd | NVCR | Cordova Ashley Chief Financial Officer |
828 | $138.23 | $114,456 | 41,967 (Direct) |
View |
| 2021-09-02 Sale |
2021-09-07 4:35 pm |
NovoCure Ltd | NVCR | GROENHUYSEN WILHELMUS CM Chief Operating Officer |
181 | $138.23 | $25,020 | 149,899 (Direct) |
View |
| 2021-09-02 Sale |
2021-09-07 4:32 pm |
NovoCure Ltd | NVCR | Shah Pritesh Chief Commercial Officer |
657 | $138.57 | $91,041 | 73,512 (Direct) |
View |
| 2021-08-12 Sale |
2021-08-16 4:40 pm |
NovoCure Ltd | NVCR | Cordova Ashley Chief Financial Officer |
26,624 | $140.94 | $3,752,286 | 68,477 (Direct) |
View |
| 2021-08-05 Sale |
2021-08-06 4:44 pm |
NovoCure Ltd | NVCR | Madden Martin J. Director |
34 | $153.13 | $5,206 | 16,004 (Indirect Direct) |
View |
| 2021-08-04 Sale |
2021-08-06 4:41 pm |
NovoCure Ltd | NVCR | Shah Pritesh Chief Commercial Officer |
2,063 | $148.71 | $306,789 | 74,169 (Direct) |
View |
| 2021-08-05 Sale |
2021-08-06 4:39 pm |
NovoCure Ltd | NVCR | LEUNG GABRIEL Director |
1,000 | $152.5 | $152,500 | 75,204 (Direct) |
View |
| 2021-08-02 Sale |
2021-08-04 5:20 pm |
NovoCure Ltd | NVCR | Leonard Frank X Chief Development Officer |
1,041 | $149.39 | $155,520 | 89,158 (Direct) |
View |
| 2021-08-03 Sale |
2021-08-04 5:09 pm |
NovoCure Ltd | NVCR | Shah Pritesh Chief Commercial Officer |
1,654 | $149.43 | $247,157 | 76,232 (Direct) |
View |
| 2021-08-02 Sale |
2021-08-04 5:01 pm |
NovoCure Ltd | NVCR | DOYLE WILLIAM F Executive Chairman |
995 | $149.38 | $148,631 | 554,398 (Direct) |
View |
| 2021-08-03 Sale |
2021-08-04 4:59 pm |
NovoCure Ltd | NVCR | Benaim Ely Chief Medical Officer |
464 | $150.11 | $69,651 | 28,144 (Direct) |
View |
| 2021-07-30 Sale |
2021-08-03 5:29 pm |
NovoCure Ltd | NVCR | Benaim Ely Chief Medical Officer |
1,187 | $154.63 | $183,550 | 31,861 (Direct) |
View |
| 2021-07-06 Sale |
2021-07-08 5:23 pm |
NovoCure Ltd | NVCR | LEUNG GABRIEL Director |
1,000 | $183.54 | $183,540 | 76,204 (Direct) |
View |
| 2021-06-10 Sale |
2021-06-11 4:26 pm |
NovoCure Ltd | NVCR | Shah Pritesh Chief Commercial Officer |
23,540 | $215 | $5,061,100 | 77,732 (Direct) |
View |
| 2021-06-09 Sale |
2021-06-11 4:21 pm |
NovoCure Ltd | NVCR | HILLEMAN JERYL L Director |
1,270 | $210.01 | $266,713 | 4,443 (Direct) |
View |
| 2021-06-07 Sale |
2021-06-08 4:49 pm |
NovoCure Ltd | NVCR | LEUNG GABRIEL Director |
1,000 | $204.55 | $204,550 | 76,390 (Direct) |
View |
| 2021-05-27 Sale |
2021-05-28 4:36 pm |
NovoCure Ltd | NVCR | Benaim Ely Chief Medical Officer |
1,833 | $200 | $366,600 | 36,386 (Direct) |
View |
| 2021-05-12 Sale |
2021-05-14 4:07 pm |
NovoCure Ltd | NVCR | Benaim Ely Chief Medical Officer |
1,943 | $180.48 | $350,673 | 29,054 (Direct) |
View |
| 2021-05-10 Sale |
2021-05-12 4:15 pm |
NovoCure Ltd | NVCR | Benaim Ely Chief Medical Officer |
4,095 | $184.38 | $755,055 | 40,162 (Direct) |
View |
| 2021-05-10 Sale |
2021-05-12 4:13 pm |
NovoCure Ltd | NVCR | Weinberg Uri Chief Science Officer |
5,650 | $189.65 | $1,071,523 | 35,512 (Direct) |
View |
| 2021-05-05 Sale |
2021-05-06 4:17 pm |
NovoCure Ltd | NVCR | Shah Pritesh Chief Commercial Officer |
1,290 | $199.67 | $257,574 | 101,272 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2022-01-03 Exercise |
2022-01-05 4:52 pm |
N/A N/A |
NovoCure Ltd | NVCR | Burke William Patrick Chief Human Resources Officer |
1,402 | $21.6 | 56,968 (Direct) |
View |
| 2022-01-03 Exercise |
2022-01-05 4:52 pm |
N/A 2026-02-24 |
NovoCure Ltd | NVCR | Burke William Patrick Chief Human Resources Officer |
28,604 | $0 | 56,968 (Direct) |
View |
| 2022-01-03 Exercise |
2022-01-05 4:52 pm |
N/A N/A |
NovoCure Ltd | NVCR | Burke William Patrick Chief Human Resources Officer |
9,750 | $7.15 | 56,968 (Direct) |
View |
| 2022-01-03 Exercise |
2022-01-05 4:52 pm |
N/A N/A |
NovoCure Ltd | NVCR | Burke William Patrick Chief Human Resources Officer |
17,452 | $11.46 | 56,968 (Direct) |
View |
Ownership |
2021-09-03 4:34 pm |
N/A N/A |
NovoCure Ltd | NVCR | Burke William Patrick Chief Human Resources Officer |
0 | $0 | 134,931 (Direct) |
View |
| 2021-08-12 Exercise |
2021-08-16 4:40 pm |
N/A N/A |
NovoCure Ltd | NVCR | Cordova Ashley Chief Financial Officer |
5,927 | $19.25 | 68,477 (Direct) |
View |
| 2021-08-12 Exercise |
2021-08-16 4:40 pm |
N/A N/A |
NovoCure Ltd | NVCR | Cordova Ashley Chief Financial Officer |
10,000 | $15.6 | 68,477 (Direct) |
View |
| 2021-08-12 Exercise |
2021-08-16 4:40 pm |
N/A N/A |
NovoCure Ltd | NVCR | Cordova Ashley Chief Financial Officer |
7,298 | $47.04 | 68,477 (Direct) |
View |
| 2021-08-12 Gift |
2021-08-16 4:40 pm |
N/A N/A |
NovoCure Ltd | NVCR | Cordova Ashley Chief Financial Officer |
1,733 | $0 | 68,477 (Direct) |
View |
| 2021-08-12 Exercise |
2021-08-16 4:40 pm |
N/A N/A |
NovoCure Ltd | NVCR | Cordova Ashley Chief Financial Officer |
8,026 | $21.5 | 68,477 (Direct) |
View |
| 2021-08-12 Exercise |
2021-08-16 4:40 pm |
N/A N/A |
NovoCure Ltd | NVCR | Cordova Ashley Chief Financial Officer |
2,606 | $69.37 | 68,477 (Direct) |
View |
| 2021-08-12 Exercise |
2021-08-16 4:40 pm |
N/A N/A |
NovoCure Ltd | NVCR | Cordova Ashley Chief Financial Officer |
2,767 | $32.02 | 68,477 (Direct) |
View |
| 2021-08-12 Exercise |
2021-08-16 4:40 pm |
N/A 2025-04-22 |
NovoCure Ltd | NVCR | Cordova Ashley Chief Financial Officer |
36,624 | $0 | 68,477 (Direct) |
View |
| 2021-08-10 Gift |
2021-08-12 4:22 pm |
N/A 2026-01-12 |
NovoCure Ltd | NVCR | GROENHUYSEN WILHELMUS CM Chief Operating Officer |
640 | $0 | 147,048 (Direct) |
View |
| 2021-08-05 Exercise |
2021-08-06 4:39 pm |
N/A N/A |
NovoCure Ltd | NVCR | LEUNG GABRIEL Director |
1,000 | $31.45 | 75,204 (Direct) |
View |
| 2021-08-05 Exercise |
2021-08-06 4:39 pm |
N/A 2028-05-30 |
NovoCure Ltd | NVCR | LEUNG GABRIEL Director |
1,000 | $0 | 75,204 (Direct) |
View |
| 2021-07-30 Exercise |
2021-08-03 5:29 pm |
N/A 2029-07-30 |
NovoCure Ltd | NVCR | Benaim Ely Chief Medical Officer |
651 | $0 | 31,861 (Direct) |
View |
| 2021-07-30 Exercise |
2021-08-03 5:29 pm |
N/A N/A |
NovoCure Ltd | NVCR | Benaim Ely Chief Medical Officer |
651 | $83.3 | 31,861 (Direct) |
View |
| 2021-07-06 Option Award |
2021-07-08 5:38 pm |
N/A N/A |
NovoCure Ltd | NVCR | Weinberg Uri Chief Science Officer |
113 | $137.12 | 31,780 (Direct) |
View |
| 2021-07-06 Option Award |
2021-07-08 5:36 pm |
N/A N/A |
NovoCure Ltd | NVCR | Leonard Frank X Chief Development Officer |
154 | $137.12 | 90,199 (Direct) |
View |
| 2021-07-06 Option Award |
2021-07-08 5:35 pm |
N/A N/A |
NovoCure Ltd | NVCR | Cordova Ashley Chief Financial Officer |
100 | $137.12 | 35,993 (Direct) |
View |
| 2021-07-06 Option Award |
2021-07-08 5:34 pm |
N/A N/A |
NovoCure Ltd | NVCR | GROENHUYSEN WILHELMUS CM Chief Operating Officer |
66 | $137.12 | 150,080 (Direct) |
View |
| 2021-07-06 Option Award |
2021-07-08 5:32 pm |
N/A N/A |
NovoCure Ltd | NVCR | Benaim Ely Chief Medical Officer |
90 | $137.12 | 29,144 (Direct) |
View |
| 2021-07-06 Option Award |
2021-07-08 5:31 pm |
N/A N/A |
NovoCure Ltd | NVCR | Danziger Asaf Chief Executive Officer |
118 | $137.12 | 8,302 (Direct) |
View |
| 2021-07-06 Option Award |
2021-07-08 5:29 pm |
N/A N/A |
NovoCure Ltd | NVCR | Shah Pritesh Chief Commercial Officer |
154 | $137.12 | 77,886 (Direct) |
View |
| 2021-07-06 Option Award |
2021-07-08 5:26 pm |
N/A N/A |
NovoCure Ltd | NVCR | Longsworth Todd Christopher General Counsel |
154 | $137.12 | 67,868 (Direct) |
View |
| 2021-07-06 Exercise |
2021-07-08 5:23 pm |
N/A N/A |
NovoCure Ltd | NVCR | LEUNG GABRIEL Director |
1,000 | $31.45 | 76,204 (Direct) |
View |
| 2021-07-06 Exercise |
2021-07-08 5:23 pm |
N/A 2028-05-30 |
NovoCure Ltd | NVCR | LEUNG GABRIEL Director |
1,000 | $0 | 76,204 (Direct) |
View |
| 2021-06-09 Option Award |
2021-06-11 4:24 pm |
N/A 2031-06-09 |
NovoCure Ltd | NVCR | McCoy Sherilyn S Director |
2,313 | $0 | 8,213 (Direct) |
View |
| 2021-06-09 Option Award |
2021-06-11 4:22 pm |
N/A 2031-06-09 |
NovoCure Ltd | NVCR | Madden Martin J. Director |
2,313 | $0 | 17,537 (Direct) |
View |
| 2021-06-09 Option Award |
2021-06-11 4:22 pm |
N/A 2031-06-09 |
NovoCure Ltd | NVCR | VERNON W ANTHONY Director |
2,313 | $0 | 163,443 (Direct) |
View |
| 2021-06-09 Option Award |
2021-06-11 4:21 pm |
N/A 2031-06-09 |
NovoCure Ltd | NVCR | HILLEMAN JERYL L Director |
2,313 | $0 | 4,443 (Direct) |
View |
| 2021-06-09 Option Award |
2021-06-11 4:19 pm |
N/A 2031-06-09 |
NovoCure Ltd | NVCR | Hung David Director |
2,313 | $0 | 8,213 (Direct) |
View |
| 2021-06-09 Option Award |
2021-06-11 4:18 pm |
N/A 2031-06-09 |
NovoCure Ltd | NVCR | LEUNG GABRIEL Director |
2,313 | $0 | 74,358 (Direct) |
View |
| 2021-06-07 Exercise |
2021-06-08 4:49 pm |
N/A N/A |
NovoCure Ltd | NVCR | LEUNG GABRIEL Director |
1,000 | $31.45 | 76,390 (Direct) |
View |
| 2021-06-07 Exercise |
2021-06-08 4:49 pm |
N/A 2028-05-30 |
NovoCure Ltd | NVCR | LEUNG GABRIEL Director |
1,000 | $0 | 76,390 (Direct) |
View |
| 2021-05-27 Exercise |
2021-05-28 4:36 pm |
N/A N/A |
NovoCure Ltd | NVCR | Benaim Ely Chief Medical Officer |
1,833 | $47.56 | 36,386 (Direct) |
View |
| 2021-05-27 Exercise |
2021-05-28 4:36 pm |
N/A 2029-05-07 |
NovoCure Ltd | NVCR | Benaim Ely Chief Medical Officer |
1,833 | $0 | 36,386 (Direct) |
View |
| 2021-05-10 Exercise |
2021-05-12 4:15 pm |
N/A N/A |
NovoCure Ltd | NVCR | Benaim Ely Chief Medical Officer |
1,833 | $47.56 | 40,162 (Direct) |
View |
| 2021-05-10 Exercise |
2021-05-12 4:15 pm |
N/A 2029-05-07 |
NovoCure Ltd | NVCR | Benaim Ely Chief Medical Officer |
1,833 | $0 | 40,162 (Direct) |
View |
| 2021-05-10 Exercise |
2021-05-12 4:13 pm |
N/A N/A |
NovoCure Ltd | NVCR | Weinberg Uri Chief Science Officer |
3,846 | $47.56 | 35,512 (Direct) |
View |
| 2021-05-10 Exercise |
2021-05-12 4:13 pm |
N/A 2029-05-07 |
NovoCure Ltd | NVCR | Weinberg Uri Chief Science Officer |
3,846 | $0 | 35,512 (Direct) |
View |